Analysis of irises with a latanoprost-induced change in iris color

American Journal of Ophthalmology

Volumn 138, Issue 4, 2004, Pages 625-630

  Arranz Marquez, Esther ^a,b,e   Teus, Miguel A ^a,c   Saornil, M Antonia ^d   Mendez, M Carmen ^d   Gil, Raquel ^a  

^a Hosp Oftalmologico Internacional M   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d UNIVERSITY OF VALLADOLID   (Spain)

^e Madrid Spain   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; MELANIN;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EYE BIOPSY; EYE COLOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; MALE; MELANOCYTE; MORPHOLOGY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; STROMA; TISSUE LEVEL; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BIOPSY; EXFOLIATION SYNDROME; EYE COLOR; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INCLUSION BODIES; IRIS; IRIS DISEASES; MALE; MELANINS; MELANOCYTES; MELANOSIS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC;

EID: 7044237146     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.06.017     Document Type: Article

References (14)

1. G. Selén, J. Stjernschantz, B. Resul Prostaglandin-induced iridial pigmentation in primates Surv Ophthalmol 41 2 suppl 1997 S125 S128
2. A. Alm, J. Stjernschantz Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning A comparison with timolol. Scandinavian Latanoprost Study Group Ophthalmology 102 1995 1743 1752
3. M.A. Teus, E. Arranz-Marquez, P. Lucea-Suescun Incidence of iris color change in latanoprost treated eyes Br J Ophthalmol 86 2002 1085 1088
4. C.B. Camras, A. Alm, P. Watson, J. Stjernschantz Latanoprost, a prostaglandin analog, for glaucoma therapy Efficacy and safety after one year of treatment in 198 patients. Latanoprost Study Groups Ophthalmology 103 1996 1916 1924
5. N.G. Lindquist, B.S. Larsson, J. Stjernschantz Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue Exp Eye Res 69 1999 431 436
6. N. Pfeiffer, I. Grierson, H. Goldsmith, D. Hochgesand, A. Winkgen-Bohres, P. Appleton Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study Arch Ophthalmol 119 2001 191 196
7. J.D. Lindsey, H.L. Jones, E.G. Hewitt, M. Angert, R.N. Weinreb Induction of tyrosinase gene transcription in human iris organ cultures exposed to latanoprost Arch Ophthalmol 119 2001 853 860
8. N. Pfeiffer, I. Grierson, H. Goldsmith, P. Appleton, D. Hochgesand, A. Winkgen Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study) Arch Ophthalmol 121 2003 23 31
9. D.M. Albert, W.R. Green, M.L Zimbric Iris melanocyte numbers in Asian, African American, and Caucasian irides Trans Am Ophthalmol Soc 101 2003 217 221
10. P.D. Imesch, I.H. Wallow, D.M. Albert The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation Surv Ophthalmol 41 2 suppl 1997 S117 S123
11. W.H. Spencer Ophthalmic pathology: an atlas and textbook 3rd ed 1986 WB Saunders Philadelphia 1352-1364
12. M.S. Sunba, A.H. Rahi, G. Morgan Tumours of the anterior uvea II. Intranuclear cytoplasmic inclusions in malignant melanoma of the iris Br J Ophthalmol 64 1980 453 456
13. I. Grierson, W.R. Lee, D.M. Albert The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change Arch Ophthalmol 117 1999 394 396
14. A. Sugita, T. Tanaka, H. Yoshioka Age-related changes of iris stromal melanocytes in human eyes Jpn J Ophthalmol 30 1986 174 179